Conclusions
In as little as a decade whole-body PET imaging has emerged as an essential component of medical imaging in oncology. Rather than being a competitor of CT based anatomical diagnosis in body oncology imaging, the complimentary value of metabolic diagnosis provided by PET and anatomical diagnosis provided by CT is now manifest in combined PET/CT scanners, which likely will quickly become the standard for body oncology medical diagnosis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Shreve PD. Status of clinical PET in the USA and the role and activities of the institute for clinical PET. In: Positron Emission Tomography: A Critical Assessment of Recent Trends. [Bulyas B and Muller-Gartner HW, Eds] Dordrecht: Kluwer 1998:33–42.
Phelps ME, Hoffman EJ, Mullani NA, Ter-Pogossian MM. Application of annihilation coincidence detection to transaxail reconstruction tomography. J Nucl Med 1975;16:210–224.
Ter-Pogossian MM, Phelps ME, Hoffman EJ, et. al. A positron-emission transaxial tomograph for nuclear medicine imaging (PETT). Radiology 1975;114:89–98.
Willimas, Crabtree, Burgiss. Design and performance characteristics of a positron emission computed axial tomograph-ECAT-II. IEEE Trans Nucl Sci 1979;26.
Hoffman EJ, Phelps ME, Huang S-C. Perfomance evaluation of a positron tomograph designed for brain imaging. J Nucl Med 1983;24:245–257.
Casey ME, Nutt R. A multicrystal two-dimensional BGO detector system for postiron emission tomography. IEEE Trans. Nucl Sci 1986;NS33:460–463.
Gupta NC, Frank AR, Dewan NA, et. al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2Deoxy-D-glucose. Radiology 1992;184:441–444.
Glaspy JA, Hawkins R, Hoh CK, Phelps ME. Use of positron emission tomography in oncology. Oncology 1993;7:41–50.
Price P. Is there a future for PET in oncology. Eur J Nucl Med 1997;24:587–589.
Wahl RL, Zasadny K, Helvie M, Hutchins GD, Weber B, Cody R. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Onc 1993;11:2101–2111.
Rigo P, Paulus P, Kaschten BJ, et. al. Oncologic applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996;23:1641–1674.
Muehllehner G, Karp JS, Mankoff DA, Beerbohm, Ordonez CE. Design and performance of a new positron emission tomograph. IEEE Trans Nucl Sci 1988;35:670–674.
Karp JS, Muehllehner G, Qu H, Yan X-H. Singles transmission in volume-imaging PET with a 137Cs source. Phys Med Biol 1995;40:929–944.
Townsend DL, Wensveen M, Byars LG, et. al. A rotating PET scanner using BGO block detectors: design, performance, and applications. J Nucl Med 1993;34:1367–1376.
Mullani NA, Gould KL, Hitchens RE, et. al. Design and performance of POSICAM 6.5 BGO positron camera. J Nucl Med 1990;31:610–616.
Wienhard K, Eriksson L, Grootoonk S, Casey M, Pietrzyk U, Heiss W. Performance evaluation of the positron scanner ECAT EXACT. JCAT 1992;16:804–813.
DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman J, Coleman RE. Performance characteristics of a whole-body PET scanner. J Nucl Med 1994;35:1398–1406.
Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Tans Med Imaging. 1994;13:601–609.
Xu M, Cutler PD, Luk WK. Adaptive, segmented attenuation correction for whole-body PET imaging. IEEE Trans Nucl Sci. 1996;43:331–336.
Wahl RW. To AC or not to AC: that is the question. J Nucl Med 1999;40:2025–2028.
Kinahan PE, Rogers JG. Analytic 3D image reconstruction using all detected events. IEEE Tans. Nucl. Sci. 1989;36:964–968.
Townsend DW, Geissbuhler A, Defrise M, et. al. Fully three-dimensional reconstruction for a PET camera with retractable septa. IEEE Tans. Med. Imaging 1991;MI-10:505–512.
Muehllehner G. Design considerations for PET scanners. Quarterly Journal of Nuclear Medicine. 2002;45: 16–23.
Watson CC. New, faster, image-based scatter correction for 3D PET. IEEE 2000;47:1587–1594.
Beyer T, Townsend DW, Brun T, et. al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000;41:1369–1379.
Shreve PD. Adding structure to function. J Nucl Med 2000;41:1380–1382.
Kinahan PE. Townsend DW, Beyer T, Sashin D. Attenuation correction for a combined 3D PET/CT scanner. Med. Phys. 1998;25:2046–2053.
Halpern B, Dahlbom M, Vranjesevic D, et. al. LSO-PET/CT whole-body imaging in 7 minutes: is it feasible? J Nucl Med 2003;44:380–381.
Bar-Shalom R, Yefremov N, Guralnik L, et. al. Clinical performance of PET/CT in evaluation of cancer: Additional value for diagnostic imaging and patient management. J Nucl Med 2003;44:1200–1209.
Cohade C, Osman M, Leal J, Wahl RL. Direct comparison of 18F-FDG and PET/CT in patients with colorectal carcinoma. J Nucl Med 2003;44:1797–1803.
Ollenberger GP, Weder W, von Schulthess GK, Steinert HC. Staging of lung cancer with integrated PET-CT. N Engl J Med 2004;350:86–87.
Shreve, PD, Anzai Y, Wahl RW. Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants. Radiographics 1999;19:61–67.
Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration of FDG uptake in cancer: a PET study. J Nucl Med 1993;34:1–6.
Vesselle HJ, Miraldi FD. FDG PET of the retroperitoneum: normal anatomy, variants, pathological conditions, and strategies to avoid diagnostic pitfalls. RadioGraphics 1998;18:805–823.
Brigid GA, Flanagan FL, Dehdashti F. Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations. AJR 1997;169:1675–1680.
Miraldi F, Vesselle H, Faulhaber PF, Adler LP, Leisure GP. Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer. Clin Nucl Med 1998;23:3–7.
Stahl A, Weber W, Avril N, Schwaiger M. The effect of N-butylscopolamine on intestinal uptake of F-18 fluorodeoxyglucose in PET imaging of the abdomen. Eur J Nucl Med 1999;26(P):1017.
Kostakoglu L, Wong JCH, barrington SF, Cronin BF, Dynes AM, Maisey MN. Speech-related visualization of laryngeal muscles with fluorine-18 FDG. J Nucl Med 1996;37:1771–1773.
Hany TF, Gharelpapagh E, Kamel E, Buch A, Himms-Hagen J, von Schulthess G. Brown adipose tissue: a factor to consider in symetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging 2002;29:1393–1398.
Cohade C, Osman M, Pannu HK, Wahl RL. Uptake in supraclavicular area fat (“USA-Fat”): Description on 18F-FDG PET/CT. J Nucl Med 2003;44:170–176.
Yeung HWD, Grewal RK, Gonen M, Schoder H, Larson SM. Patterns of 18-F FDG uptake in adipose tissue and muscle: A potential source of false-positives for PET. J Nucl Med 2003;44:1789–1796.
Barrington SF, Maisey MN. Skeletal muscle uptake of fluorine-18-FDG: effect on oral diazepam. J Nucl Med 1996;37:1127–1129.
Beyer T. Personnel communication.
Beyer T, Antoch G, Muller S, Egelhof T, Freudenberg LS, Debatin J, Bockisch A. Acquisition protocol considerations for combined PET/CT imaging. J Nucl Med 2004;45:25S–35S.
Jones SC, Alavi A, Christman D, Montanez I, Wolf AP, Reivich M. The radiation dosimetry of 2-[F-18]fluoro-2Deoxy-D-glucose in man. J Nucl Med 1982;23:613–617.
Hamberg LM, Hunter GJ, Alpert NM, Choi NC, Babich JW, Fischman AJ. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med 1994;35:1308–1312.
Lowe V. Personnel communication.
Keyes JW Jr. SUV: standard uptake value or silly useless value? J Nucl Med 1995;36:1836–1839.
Kostakoglu L, Goldsmith SJ. 18F FDG PET evaluation of the response to therapy for lymphoma and for breast, lung and colorectal carcinoma. J Nucl Med 2003;44:224–239.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag London Limited
About this chapter
Cite this chapter
Shreve, P.D. (2005). Whole-Body PET Imaging Methods. In: Bailey, D.L., Townsend, D.W., Valk, P.E., Maisey, M.N. (eds) Positron Emission Tomography. Springer, London. https://doi.org/10.1007/1-84628-007-9_13
Download citation
DOI: https://doi.org/10.1007/1-84628-007-9_13
Publisher Name: Springer, London
Print ISBN: 978-1-85233-798-8
Online ISBN: 978-1-84628-007-8
eBook Packages: MedicineMedicine (R0)